Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Alliance Pharma COO stepping down, position to be disestablished

(Sharecast News) - Healthcare products group Alliance Pharma announced on Tuesday that its chief operating officer Jeyan Heper would leave the company on 31 August. The AIM-traded firm said Heper joined on 1 February 2023, playing a significant role in identifying growth opportunities in international consumer healthcare markets and assisting the board and senior executive team in developing strategies for markets, especially in China and the US.

In a move to accelerate globalisation, bring consumers closer to the core of the business, and streamline the management structure, the board said it had decided to eliminate the COO position.

"I want to thank Jeyan for his contribution to Alliance, providing stability and valuable international consumer healthcare insights as we continue on our journey to transform to a high performing consumer healthcare company, built on a portfolio of leading, trusted and proven brands," said chief executive officer Nick Sedgwick.

"We wish him well in his future endeavours."

At 1140 BST, shares in Alliance Pharma were down 0.54% at 36.8p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

ECR Minerals mulls expansion into US helium market
(Sharecast News) - ECR Minerals, an exploration and development company traditionally focused on gold in Australia, announced on Friday that its board was exploring potential investments in producing helium assets in the United States.
Zenova reports solid momentum as interim loss narrows
(Sharecast News) - Fire safety and heat management technology specialist Zenova Group reported significant first-half strides in its interim results on Friday, despite a challenging financial backdrop.
Jefferies lowers target price on Life Science REIT
(Sharecast News) - Jefferies cut its price target on real estate investment trust Life Sciences REIT from 45.0p to 36.0p following a visit to the group's Cambourne Science & Technology Park.
Beowulf reports substantial first-half progress
(Sharecast News) - Mineral explorer and developer Beowulf Mining reported substantial progress across its portfolio in its interim results on Friday, particularly in advancing its key projects at Gállok in Sweden and the Graphite Anode Materials Plant (GAMP) in Finland.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.